InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Reardon Tighe, Chief Financial Officer. Officer active across 1 company, notably Janux Therapeutics, Inc.. Aggregated, 3 reports have been logged. Breakdown: 1 buy · 1 sell. Total volume traded: €11.3m. History available since 13 November 2023. The latest transaction was disclosed on 3 June 2024 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Tighe Reardon serves as the Acting Chief Financial Officer at Janux Therapeutics, Inc. He is responsible for overseeing the company's financial operations, including budgeting and financial analysis. His expertise contributes to the effective management of financial resources and strategic decision-making.